CPT1A and prostate carcinoma: Exosomes from prostate cancer cells further impair tumor-infiltrating CD8+ T cells by releasing IL-8, which activates PPARα in receptor cells and subsequently upregulates CPT1A expression in tumor cells, disrupting energy metabolism [134].